-
A new report by AARP found that the top 25 drugs — covered under Medicare Part D — have almost tripled in price since they first entered the market.
-
To drive down costs, insurers are delivering high-priced infusion drugs via third-party pharmacies. Hospitals and clinics are trying to convince states to limit this practice, known as "white bagging."
-
The House Appropriations Committee on Friday approved a bill that would make a series of changes to regulate PBMs. The Senate unanimously passed its version on Wednesday.
-
The Inflation Reduction Act gives Medicare historic new powers to limit prescription drug prices. But the pharmaceutical industry is already lobbying to dull their impact.
-
Democrats agreed to a significant — but slimmed down — proposal to help lower prescription drug prices, bringing aboard notable holdouts on the measure, including Arizona Sen. Kyrsten Sinema.
-
Three groups argue that HHS Secretary Alex Azar is “punting” to the states the responsibility for demonstrating the imports will be safe and save costs.
-
The House of Representatives is expected to approve a bill Thursday that aims to lower prescription drug prices. Some elements have Republican support. But the bill faces an uncertain Senate future.
-
The bipartisan legislation proposes plans to deal with surprise medical bills, prescription drug patents, price transparency and vaccine education.
-
About 1.6 million Floridians are enrolled in Affordable Care Act Marketplace plans. Open enrollment starts Nov. 1 and ends Dec. 15. Florida Blue offers...
-
The 39-page drug price plan includes an array of ideas that the administration will consider, but it's unclear which ones will be implemented.